RxDoctor Payments Data

Jessica Goralski, PA

Physician Assistant · Torrington, CTNPI 1396467478

Payments from drug & device makers

$2,970in general payments, 2019–2025

Across 158 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$717
  • Takeda Pharmaceuticals U.S.A., Inc.$649
  • Phathom Pharmaceuticals, Inc.$265
  • Sanofi$202
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$197
  • Johnson & Johnson$126
  • plus $814 from 16 others

What the payments were for

  • Food & beverage$2,91898%
  • Education$522%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,970 in reported general payments places this provider in the 90th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$29,857
Medicare patients
249
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide116$100,979
XifaxanRifaximin22$73,463
ZenpepLipase/Protease/Amylase12$33,836
Dexlansoprazole DrDexlansoprazole35$21,400
DexilantDexlansoprazole17$14,854
NexiumEsomeprazole Magnesium13$12,037
Pantoprazole Sodium458$9,889
Mesalamine27$7,309
SutabSod Sulf/Pot Chloride/Mag Sulf41$6,739
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates89$5,531
Omeprazole223$3,920
Lubiprostone15$3,875
Esomeprazole Magnesium53$3,791
Famotidine199$3,336
Sucralfate38$3,140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$717$100,979116 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$197$73,46322 claims
Aimmune Therapeutics, Inc.Zenpep$29$33,83612 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$649$14,85417 claims
Braintree Laboratories, Inc.Sutab$17$6,73941 claims
Ferring Pharmaceuticals Inc.Clenpiq$112$2,07111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,795 physician assistant providers in Connecticut.

Other physician assistant in Torrington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →